FreeCME
ABSTRACT & COMMENTARY

Second-line Docetaxel Improves Survival and Symptom Control in Advanced Esophagogastric Cancer

March 1, 2014
/ Print / Reprints /
| Share More
/ Text Size+

Optimizing the Management of Relapsed Refractory Chronic Lymphocytic Leukemia

OncologyCME

thumbnail

Partner with Us

freeCME.com® provides unparalleled opportunities for partners.